By: Leslie S. Baumann, M.D.
Everyone in the skin care world is talking about sirtuins. Studies have shown that resveratrol activates sirtuins, and sales of resveratrol have risen. Many products claim to contain ingredients that activate sirtuins.
To be up to date on current skin care, you need to know what sirtuins are and why they are a frequent topic at the Society of Cosmetic Chemists meetings. The short explanation is that calorie-restricted mice have been shown to live longer and to have increased expression of sirtuins. It is believed that the upregulation of sirtuin expression is associated with increased longevity. When mice were not calorie restricted but were treated with resveratrol to activate sirtuins, they also lived longer.
The current belief that activating sirtuin is desirable has led to a plethora of products with sirtuin-activating ingredients, including several sold by Avon Products Inc.
Where Are Sirtuins Found?
Role of Sirtuins
Silent mating type information regulator 2 (Sir2) proteins, or sirtuins, are a family of nicotinamide adenine dinucleotide (NAD+)-dependent enzymes known to deacetylate lysine residues on several proteins and, in some cases, to exhibit adenosine diphosphate (ADP)-ribosyltransferase activity (Genome Biol. 2004;5:224; Mol. Endocrinol. 2007;21:1745-55). Sirtuins are activated when cellular energy is low and the NAD+ to NADH ratio is high (Genes Nutr. 2006;1:85-93).
This family of enzymes is known to be involved in apoptosis, fatty acid metabolism, gene silencing, and regulation of cellular lifespans. They are also linked to genes that organize and optimize cell functions to resist or survive in stressful environments (J. Drugs Dermatol. 2007;6:s14-9). Sirtuins regulate important biological pathways, such as transcriptional repression, recombination, the cell-division cycle, microtubule organization, and cellular responses to DNA-damaging compounds (Genome Biol. 2004;5:224).
It is believed that the mammalian sirtuins, SIRT1-SIRT7, play an influential role in gene silencing, energy homeostasis, the cell cycle, apoptosis, stress resistance or stress responses, axonal degeneration, and aging (Genome Biol. 2004;5:224; Mol. Endocrinol. 2007;21:1745-55; J. Cell Mol. Med. 2008 Aug 4 [doi:10.1111/j.1582-4934.2008.00453.x ]). As such, Yamamoto et al. have contended that sirtuins may be appropriate therapeutic targets for a range of disorders, including proliferative, neurodegenerative, and metabolic diseases (Mol. Endocrinol. 2007;21:1745-55).
The Nomenclature
Sirtuin Research in Skin
For the active skin care product portion of the study, the researchers enrolled 33 women between 37 and 64 years old (mean age 51.6 years), who were instructed to apply a formulation enriched in 1% of the yeast biopeptides once daily for 4 weeks to the neck and face. Before and after the first application and after 4 weeks of use, investigating dermatologists assessed fine lines and wrinkles, pigment color intensity, complexion homogeneity, and radiance, as well as skin density, hydration, firmness, and texture on a 1-9 scale. To objectively evaluate skin care efficacy, they used a pixel skin method based on analyzing age-related parameters from numerical pictures of faces.
The investigators identified multiple findings from their study. In particular, the Kluyveromyces biopeptides markedly increased SIRT1 expression in normal human dermal fibroblasts in vitro as well as in healthy human epidermal cells ex vivo while diminishing cellular aging and UVB-induced DNA fragmentation. Among the study participants, improvements were found in all of the assessment parameters, with hydration noted as significantly improving right after the first application.
| Feb 4 - 8 Maui, HI | Advances in Cosmetic & Medical Dermatology (MauiDerm 2012) |
| Feb 8 - 12 Naples, FL | Dermatology Foundation (DF): Clinical Symposia |
| Feb 16 - 20 Miami Beach, FL | 2012 South Beach Symposium |
| Feb 19 - 24 Waikoloa, HI | Skin Disease Education Foundation (SDEF): Hawaii Dermatology Seminar |
| Feb 20 - 23 Jeddah, | King Faisal Specilalist Hospital - Jeddah: Jeddah Dermatology & Cosmetics Conference |
| Mar 1 - 4 Banff, | 2012 Canadian Melanoma Conference |
| Mar 14 - 15 San Diego, CA | International Society of Dermatopathology (ISDP): 15th Joint Meeting |
| Mar 14 - 17 San Diego, CA | Association of Dermatology Administrators and Managers (ADA-M): 20th Annual Meeting |
| Mar 15 San Diego, CA | Society for Pediatric Dermatology (SPD): Pre-American Academy of Dermatology Meeting |
| Mar 15 San Diego, CA | 16th Annual Meeting of the Council for Nail Disorders |
Seminars In Cutaneous Medicine And Surgery
March
Psoriasis and Biologics
Craig Leonardi
June
Pediatric Dermatology
Kelly Cordoro
September
Pigmented Lesions
Michael Ming
December
Skin Cancer
Tom Rohrer
More Seminars »
This site complies with the HONcode standard for trustworthy health information: verify here.
Log in or create an account to submit your comment for this article.